How Latent Labs Plans To Create Medicines From Scratch With AI
Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...
Business Matters2d
Deepmind scientist raises $50m to use AI in protein design revolution
Former DeepMind scientist Simon Kohl has raised $50 million for Latent Labs, a London-based AI startup aiming to transform ...
SiliconRepublic5d
Latent Labs emerges from stealth to accelerate drug discovery
Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...
pharmaphorum5d
Ex-DeepMind scientist launches drug discovery company
The company has assembled a team that hails from DeepMind and Microsoft, AI in drug discovery specialist Exscientia, genomics ...
AI startup Latent Labs launches with $50m funding
The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...
STAT6d
With $40 million, former DeepMind employees launch startup ‘laser-focused’ on AI protein design
Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.
labiotech5d
DeepMind AlphaFold’s alumnus raises $40m for Latent Labs, a new AI biotech startup
Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
Latent Labs raises $50M to develop new proteins with AI
Latent Labs hopes to take computational biology one step further. The company is developing foundation AI models that don’t ...
TMCnet5d
Latent Labs Secures $50M in Funding to Realize the Potential of AI-Powered, Programmable Biology
Latent Labs, the company building AI foundation models to make biology programmable, today emerged from stealth with $50M in total funding to accelerate their progress and partnerships.